🇺🇸 FDA
Company

RECURSION

RECURSION PHARMACEUTICALS, INC.

RXRX biotech USA

Quick answer

RECURSION is a biotech company (RXRX) headquartered in SALT LAKE CITY, UT, USA with 9 tracked pipeline programs.

Pipeline (9)

project

REC-2282

Neurofibromatosis Type 2

Phase 3 · small_molecule · terminated

1 trials project

GTAEXS617

Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2 · small_molecule · active

1 trials project

REC-1245

Unresectable

Phase 2 · small_molecule · active

1 trials project

REC-3964

Recurrent Clostridioides Difficile Infection

Phase 2 · small_molecule · terminated

1 trials project

REC-4881

AXIN1 Gene Mutation

Phase 2 · small_molecule · terminated

1 trials project

REC-4881

Familial Adenomatous Polyposis

Phase 2 · small_molecule · active

1 trials project

REC-994

Cerebral Cavernous Malformation

Phase 2 · small_molecule · completed

1 trials project

EXS73565

Relapsed or Refractory B-cell Malignancies

Phase 1 · small_molecule · active

1 trials project

EXS74539

Solid Tumor

Phase 1 · small_molecule · active

1 trials

Patents (4)

patent

US 11919868

Heterocyclic compounds and related methods

Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11033494

Apparatuses containing an emulsion and methods of manufacture

Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6331564

Use of triaryl methane compounds for inhibiting unwanted cellular proliferation

Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6028103

Triaryl methane compounds and analogues thereof useful for the treatment or prev

Expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)